# Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

> **NCT01084148** · PHASE3 · COMPLETED · sponsor: **Orfagen** · enrollment: 237 (actual)

## Conditions studied

- Uremic Xerosis

## Interventions

- **DRUG:** V0034CR01B
- **DRUG:** V0034CR01B vehicle

## Key facts

- **NCT ID:** NCT01084148
- **Lead sponsor:** Orfagen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084148, "Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01084148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*